Skip to main content

Principles of Therapeutic Drug Monitoring

  • Chapter
  • First Online:
Pediatric Clinical Pharmacology

Part of the book series: Handbook of Experimental Pharmacology ((HEP,volume 205))

Abstract

Therapeutic drug monitoring (TDM) is central to optimize drug efficacy in children, because the pharmacokinetics and pharmacodynamics of most drugs differ greatly between children and adults. Many factors should be analyzed to implement TDM in the pediatric population, including a validated pharmacological parameter and an analytical method adapted to children as limited sampling volumes and high sensitivity are required. The use of population approaches, new analytical methods such as saliva and dried blood spots, and pharmacodynamic monitoring give attractive options to improve TDM, individualize therapy in order to optimize efficacy and reduce adverse drug reactions.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 389.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 499.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 499.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  • Adam BW, Alexander JR, Smith SJ, Chace DH, Loeber JG, Elvers LH, Hannon WH (2000) Recoveries of phenylalanine from two sets of dried blood spot reference materials: prediction from hematocrit, spot volume, and paper matrix. Clin Chem 46:126–128

    PubMed  CAS  Google Scholar 

  • Agunod M, Yamaguchi N, Lopez R, Luhby AL, Glass GB (1969) Correlative study of hydrochloric acid, pepsin, and intrinsic factor secretion in newborns and infants. Am J Dig Dis 14:400–414

    Article  PubMed  CAS  Google Scholar 

  • Brodehl J (1994) Consensus statements on the optimal use of cyclosporine in pediatric patients. Transplant Proc 26:2759–2762

    PubMed  CAS  Google Scholar 

  • Brunet M, Crespo M, Millan O et al (2007) Pharmacokinetics and pharmacodynamics in renal transplant recipients under treatment with cyclosporine and myfortic. Transplant Proc 39:2160–2162

    Article  PubMed  CAS  Google Scholar 

  • Carry MR, Ringel SP, Starcevich JM (1986) Distribution of capillaries in normal and diseased human skeletal muscle. Muscle Nerve 9:445–454

    Article  PubMed  CAS  Google Scholar 

  • Cheung CY, van der Heijden J, Hoogtanders K, Christiaans M, Liu YL, Chan YH, Choi KS, van de Plas A, Shek CC, Chau KF, Li CS, van Hooff J, Stolk L (2008) Dried blood spot measurement: application in tacrolimus monitoring using limited sampling strategy and abbreviated AUC estimation. Transpl Int 21:140–145

    PubMed  CAS  Google Scholar 

  • Conroy S et al (2000) Survey of unlicensed and off label drug use in paediatric wards in European countries. European Network for Drug Investigation in Children. BMJ 320:79–82

    Article  PubMed  CAS  Google Scholar 

  • Dasgupta A, Dean R, Saldana S, Konnaman G, McLawhon RW (1994) Absorption of therapeutic drugs by barrier gels in serum separator blood collection tubes. Am J Clin Pathol 101:456–461

    PubMed  CAS  Google Scholar 

  • de Hoog M, Mouton JW, van den Anker JN (2004) Vancomycin: pharmacokinetics and administration regimens in neonates. Clin Pharmacokinet 43:417–440

    Article  PubMed  Google Scholar 

  • de Jonge H, Naesens M, Kuypers DR (2009) New insights into the pharmacokinetics and pharmacodynamics of the calcineurin inhibitors and mycophenolic acid: possible consequences for therapeutic drug monitoring in solid organ transplantation. Ther Drug Monit 31:416–435

    Article  PubMed  Google Scholar 

  • del Mar Fernández De Gatta M, Santos-Buelga D, Domínguez-Gil A et al (2002) Immunosuppressive therapy for paediatric transplant patients: pharmacokinetic considerations. Clin Pharmacokinet 41:115–135

    Article  PubMed  Google Scholar 

  • Drobitch RK, Svensson CK (1992) Therapeutic drug monitoring in saliva: an update. Clin Pharmacokinet 23:365–379

    Article  PubMed  CAS  Google Scholar 

  • Edelbroek PM, van der Heijden J, Stolk LM (2009) Dried blood spot methods in therapeutic drug monitoring: methods, assays, and pitfalls. Ther Drug Monit 31:327–336

    Article  PubMed  Google Scholar 

  • Fluhr JW, Pfisterer S, Gloor M (2000) Direct comparison of skin physiology in children and adults with bioengineering methods. Pediatr Dermatol 17:436–439

    Article  PubMed  CAS  Google Scholar 

  • Fukudo M, Yano I, Masuda S et al (2005) Pharmacodynamic analysis of tacrolimus and cyclosporine in living-donor liver transplant patients. Clin Pharmacol Ther 78:168–181

    Article  PubMed  CAS  Google Scholar 

  • Gorodischer R, Burtin P, Verjee Z, Hwang P, Koren G (1997) Is saliva suitable for therapeutic monitoring of anticonvulsants in children: an evaluation in the routine clinical setting. Ther Drug Monit 19:637–642

    Article  PubMed  CAS  Google Scholar 

  • Greenblatt DJ, Koch-Weser J (1976) Intramuscular injection of drugs. N Engl J Med 295:542–546

    Article  PubMed  CAS  Google Scholar 

  • Gross AS (2001) Best practice in therapeutic drug monitoring. Br J Clin Pharmacol 52(Suppl 1):5S–10S

    Article  PubMed  Google Scholar 

  • Herkes GK, Eadie MJ (1990) Possible roles for frequent salivary antiepileptic drug monitoring in the management of epilepsy. Epilepsy Res 6:146–154

    Article  PubMed  CAS  Google Scholar 

  • Hoogtanders K, van der Heijden J, Christiaans M, Edelbroek P, van Hooff JP, Stolk LM (2007) Therapeutic drug monitoring of tacrolimus with the dried blood spot method. J Pharm Biomed Anal 44:658–664

    Article  PubMed  CAS  Google Scholar 

  • Ince I, de Wildt SN, Tibboel D, Danhof M, Knibbe CA (2009) Tailor-made drug treatment for children: creation of an infrastructure for data-sharing and population PK-PD modelling. Drug Discov Today 14:316–320

    Article  PubMed  CAS  Google Scholar 

  • Irtan S, Azougagh S, Monchaud C, Popon M, Baudouin V, Jacqz-Aigrain E (2008) Comparison of high-performance liquid chromatography and enzyme-multiplied immunoassay technique to monitor mycophenolic acid in paediatric renal recipients. Pediatr Nephrol 23:1859–1865

    Article  PubMed  Google Scholar 

  • Irtan S, Saint-Marcoux F, Rousseau A, Zhang D, Leroy V, Marquet P, Jacqz-Aigrain E (2007) Population pharmacokinetics and bayesian estimator of cyclosporine in pediatric renal transplant patients. Ther Drug Monit 29:96–102

    Article  PubMed  CAS  Google Scholar 

  • Kearns GL, Abdel-Rahman SM, Alander SW, Blowey DL, Leeder JS, Kauffman RE (2003) Developmental pharmacology–drug disposition, action, and therapy in infants and children. N Engl J Med 18(349):1157–1167

    Google Scholar 

  • Koal T, Burhenne H, Römling R, Svoboda M, Resch K, Kaever V (2005) Quantification of antiretroviral drugs in dried blood spot samples by means of liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom 19:2995–3001

    Article  PubMed  CAS  Google Scholar 

  • Koren G (1997) Therapeutic drug monitoring principles in the neonate. National Academy of Clinical Biochemistry. Clin Chem 43:222–227

    PubMed  CAS  Google Scholar 

  • la Marca G, Malvagia S, Filippi L, Fiorini P, Innocenti M, Luceri F, Pieraccini G, Moneti G, Francese S, Dani FR, Guerrini R (2008) Rapid assay of topiramate in dried blood spots by a new liquid chromatography–tandem mass spectrometric method. J Pharm Biomed Anal 48:1392–1396

    Article  PubMed  Google Scholar 

  • la Marca G, Malvagia S, Filippi L, Luceri F, Moneti G, Guerrini R (2009) A new rapid micromethod for the assay of phenobarbital from dried blood spots by LC-tandem mass spectrometry. Epilepsia 50:2658–2662

    Article  PubMed  Google Scholar 

  • Li W, Tse FL (2010) Dried blood spot sampling in combination with LC-MS/MS for quantitative analysis of small molecules. Biomed Chromatogr 24:49–65

    Article  PubMed  Google Scholar 

  • Liu H, Delgado MR (1999) Therapeutic drug concentration monitoring using saliva samples. Focus on anticonvulsants. Clin Pharmacokinet 36:453–470

    Article  PubMed  CAS  Google Scholar 

  • Marquet P, Sauvage FL, Loustaud-Ratti V, Babany G, Rousseau A, Lachâtre G (2010) Stability of ribavirin concentrations depending on the type of blood collection tube and preanalytical conditions. Ther Drug Monit 32:237–241

    PubMed  CAS  Google Scholar 

  • Mei JV, Alexander JR, Adam BW, Hannon WH (2001) Use of filter paper for the collection and analysis of human whole blood specimens. J Nutr 131:1631S–1636S

    PubMed  CAS  Google Scholar 

  • Mullangi R, Agrawal S, Srinivas NR (2009) Measurement of xenobiotics in saliva: is saliva an attractive alternative matrix? Case studies and analytical perspectives. Biomed Chromatogr 23:3–25

    Article  PubMed  CAS  Google Scholar 

  • Oellerich M, Barten MJ, Armstrong VW (2006) Biomarkers: the link between therapeutic drug monitoring and pharmacodynamics. Ther Drug Monit 28:35–38

    Article  PubMed  Google Scholar 

  • Okah FA, Wickett RR, Pickens WL, Hoath SB (1995) Surface electrical capacitance as a noninvasive bedside measure of epidermal barrier maturation in the newborn infant. Pediatrics 96:688–692

    PubMed  CAS  Google Scholar 

  • Payen S, Zhang D, Maisin A, Popon M, Bensman A, Bouissou F, Loirat C, Gomeni R, Bressolle F, Jacqz-Aigrain E (2005) Population pharmacokinetics of mycophenolic acid in kidney transplant pediatric and adolescent patients. Ther Drug Monit 27:378–388

    Article  PubMed  CAS  Google Scholar 

  • Peng B, Boddy AV, Cole M, Pearson AD, Chatelut E, Rubie H, Newell DR (1995) Comparison of methods for the estimation of carboplatin pharmacokinetics in paediatric cancer patients. Eur J Cancer 31A:1804–1810

    Article  PubMed  CAS  Google Scholar 

  • Plard C, Bressolle F, Fakhoury M, Zhang D, Yacouben K, Rieutord A, Jacqz-Aigrain E (2007) A limited sampling strategy to estimate individual pharmacokinetic parameters of methotrexate in children with acute lymphoblastic leukemia. Cancer Chemother Pharmacol 60:609–620

    Article  PubMed  Google Scholar 

  • Quattrocchi F, Karnes HT, Robinson JD, Hendeles L (1983) Effect of serum separator blood collection tubes on drug concentrations. Ther Drug Monit 5:359–362

    Article  PubMed  CAS  Google Scholar 

  • Rodbro P, Krasilnikoff PA, Christiansen PM (1967) Parietal cell secretory function in early childhood. Scand J Gastroenterol 2:209–213

    Article  PubMed  CAS  Google Scholar 

  • Rutter N (1987) Percutaneous drug absorption in the newborn: hazards and uses. Clin Perinatol 14:911–930

    PubMed  CAS  Google Scholar 

  • Sanquer S, Schwarzinger M, Maury S et al (2004) Calcineurin activity as a functional index of immunosuppression after allogeneic stem-cell transplantation. Transplantation 77:854–858

    Article  PubMed  CAS  Google Scholar 

  • Scheyer RD, Cramer JA (1990) Pharmacokinetics of antiepileptic drugs. Semin Neurol 10:414–420

    Article  PubMed  CAS  Google Scholar 

  • Schütz E, Svinarov D, Shipkova M, Niedmann PD, Armstrong VW, Wieland E, Oellerich M (1998) Cyclosporin whole blood immunoassays (AxSYM, CEDIA, and Emit): a critical overview of performance characteristics and comparison with HPLC. Clin Chem 44:2158–2164

    PubMed  Google Scholar 

  • Self TH, Heilker GM, Alloway RR, Kelso TM, Abou-Shala N (1993) Reassessing the therapeutic range for theophylline on laboratory report forms: the importance of 5–15 micrograms/ml. Pharmacotherapy 13:590–594

    PubMed  CAS  Google Scholar 

  • Sheiner LB, Beal SL (1981) Some suggestions for measuring predictive performance. J Pharmacokinet Biopharm 9:503–512

    Article  PubMed  CAS  Google Scholar 

  • Sherwin CM, Svahn S, Van der Linden A, Broadbent RS, Medlicott NJ, Reith DM (2009) Individualised dosing of amikacin in neonates: a pharmacokinetic/pharmacodynamic analysis. Eur J Clin Pharmacol 65:705–713

    Article  PubMed  CAS  Google Scholar 

  • Soldin OP, Soldin SJ (2002) Review: therapeutic drug monitoring in pediatrics. Ther Drug Monit 24:1–8

    Article  PubMed  CAS  Google Scholar 

  • Sommerer C, Giese T, Meuer S, Zeier M (2009) Pharmacodynamic monitoring of calcineurin inhibitor therapy: is there a clinical benefit? Nephrol Dial Transplant 24:21–27

    Article  PubMed  CAS  Google Scholar 

  • Steinberg C, Notterman DA (1994) Pharmacokinetics of cardiovascular drugs in children. Inotropes and vasopressors. Clin Pharmacokinet 27:345–367

    Article  PubMed  CAS  Google Scholar 

  • ‘t Jong GW et al (2000) Unapproved and off-label use of drugs in a children’s hospital. N Engl J Med 343:1125

    Article  PubMed  Google Scholar 

  • ‘t Jong GW et al (2002) Unlicensed and off-label drug use in a paediatric ward of a general hospital in the Netherlands. Eur J Clin Pharmacol 58:293–297

    Article  PubMed  Google Scholar 

  • Takahashi H, Ishikawa S, Nomoto S, Nishigaki Y, Ando F, Kashima T, Kimura S, Kanamori M, Echizen H (2000) Developmental changes in pharmacokinetics and pharmacodynamics of warfarin enantiomers in Japanese children. Clin Pharmacol Ther 68:541–555

    Article  PubMed  CAS  Google Scholar 

  • ter Heine R, Hillebrand MJ, Rosing H, van Gorp EC, Mulder JW, Beijnen JH, Huitema AD (2009a) Quantification of the HIV-integrase inhibitor raltegravir and detection of its main metabolite in human plasma, dried blood spots and peripheral blood mononuclear cell lysate by means of high-performance liquid chromatography tandem mass spectrometry. J Pharm Biomed Anal 49:451–458

    Article  PubMed  Google Scholar 

  • ter Heine R, Rosing H, van Gorp EC, Mulder JW, Beijnen JH, Huitema AD (2009b) Quantification of etravirine (TMC125) in plasma, dried blood spots and peripheral blood mononuclear cell lysate by liquid chromatography tandem mass spectrometry. J Pharm Biomed Anal 49:393–400

    Article  PubMed  Google Scholar 

  • ter Heine R, Rosing H, van Gorp EC, Mulder JW, van der Steeg WA, Beijnen JH, Huitema AD (2008) Quantification of protease inhibitors and nonnucleoside reverse transcriptase inhibitors in dried blood spots by liquid chromatography–triple quadrupole mass spectrometry. J Chromatogr B Anal Technol Biomed Life Sci 867:205–212

    Article  Google Scholar 

  • Tod MM, Padoin C, Petitjean O (2001) Individualising aminoglycoside dosage regimens after therapeutic drug monitoring: simple or complex pharmacokinetic methods? Clin Pharmacokinet 40:803–814

    Article  PubMed  CAS  Google Scholar 

  • Touw DJ, Neef C, Thomson AH, Cost-effectiveness of Therapeutic Drug Monitoring Committee of the International Association for Therapeutic Drug Monitoring and Clinical Toxicology (2005) Cost-effectiveness of therapeutic drug monitoring: a systematic review. Ther Drug Monit 27:10–17

    Article  PubMed  CAS  Google Scholar 

  • Touw DJ, Westerman EM, Sprij AJ (2009) Therapeutic drug monitoring of aminoglycosides in neonates. Clin Pharmacokinet 48:71–88

    Article  PubMed  CAS  Google Scholar 

  • van der Heijden J, de Beer Y, Hoogtanders K, Christiaans M, de Jong GJ, Neef C, Stolk L (2009) Therapeutic drug monitoring of everolimus using the dried blood spot method in combination with liquid chromatography–mass spectrometry. J Pharm Biomed Anal 50:664–670

    Article  PubMed  Google Scholar 

  • van Rossum HH, de Fijter JW, van Pelt J (2010) Pharmacodynamic monitoring of calcineurin inhibition therapy: principles, performance, and perspectives. Ther Drug Monit 32:3–10

    Article  PubMed  Google Scholar 

  • Walson PD (1998) Therapeutic drug monitoring in special populations. Clin Chem 44:415–419

    PubMed  CAS  Google Scholar 

  • Warner A, Privitera M, Bates D (1998) Standards of laboratory practice: antiepileptic drug monitoring. National Academy of Clinical Biochemistry. Clin Chem 44:1085–1095

    PubMed  CAS  Google Scholar 

  • Wilhelm AJ, den Burger JC, Vos RM, Chahbouni A, Sinjewel A (2009) Analysis of cyclosporin A in dried blood spots using liquid chromatography tandem mass spectrometry. J Chromatogr B Anal Technol Biomed Life Sci 877:1595–1598

    Article  CAS  Google Scholar 

  • Zhao W, Elie V, Baudouin V, Bensman A, André JL, Brochard K, Broux F, Cailliez M, Loirat C, Jacqz-Aigrain E (2010) Population pharmacokinetics and Bayesian estimator of mycophenolic acid in children with idiopathic nephrotic syndrome. Br J Clin Pharmacol 69:358–366

    Article  PubMed  CAS  Google Scholar 

  • Zhao W, Baudouin V, Zhang D, Deschênes G, Le Guellec C, Jacqz-Aigrain E (2009) Population pharmacokinetics of ganciclovir following administration of valganciclovir in paediatric renal transplant patients. Clin Pharmacokinet 48:321–328

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Evelyne Jacqz-Aigrain .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Zhao, W., Jacqz-Aigrain, E. (2011). Principles of Therapeutic Drug Monitoring. In: Seyberth, H., Rane, A., Schwab, M. (eds) Pediatric Clinical Pharmacology. Handbook of Experimental Pharmacology, vol 205. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-20195-0_3

Download citation

Publish with us

Policies and ethics